NYSE:CI - Cigna Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $283.44
  • Forecasted Upside: 21.71 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 9 Buy Ratings
  • 1 Strong Buy Ratings
$232.88
▲ +0.64 (0.28%)

This chart shows the closing price for CI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cigna Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CI

Analyst Price Target is $283.44
▲ +21.71% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $283.44, with a high forecast of $321.00 and a low forecast of $235.22. The average price target represents a 21.71% upside from the last price of $232.88.

This chart shows the closing price for CI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 12 contributing investment analysts is to buy stock in Cigna. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 1 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/30/2020
  • 1 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/29/2020
  • 1 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/28/2020
  • 1 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/26/2020
  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/24/2021
  • 1 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/24/2021
  • 1 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/23/2021
  • 1 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 1 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/13/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy$235.22Medium
6/3/2021Morgan StanleyBoost Price TargetOverweight$254.00 ➝ $321.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$284.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$284.00Low
5/14/2021Royal Bank of CanadaBoost Price TargetOutperform$265.00 ➝ $304.00Low
5/10/2021TruistBoost Price Target$300.00 ➝ $320.00Medium
5/10/2021Credit Suisse GroupBoost Price TargetOutperform$270.00 ➝ $300.00High
5/10/2021BMO Capital MarketsBoost Price TargetOutperform$300.00 ➝ $315.00High
5/10/2021MizuhoBoost Price TargetBuy$264.00 ➝ $290.00High
4/14/2021Truist FinancialBoost Price Target$280.00 ➝ $300.00Medium
4/14/2021Truist SecuritiesBoost Price TargetBuy$280.00 ➝ $300.00Low
3/9/2021TruistBoost Price Target$260.00 ➝ $280.00Low
3/9/2021BMO Capital MarketsBoost Price TargetOutperform$270.00 ➝ $290.00Low
3/9/2021MizuhoBoost Price TargetPositive ➝ Buy$229.00 ➝ $264.00Low
2/8/2021Morgan StanleyLower Price TargetOverweight$258.00 ➝ $254.00Low
2/5/2021CitigroupReiterated RatingBuy$273.00Medium
2/5/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy$280.00 ➝ $270.00High
12/18/2020MizuhoBoost Price TargetBuy$220.00 ➝ $229.00High
12/14/2020SVB LeerinkBoost Price TargetMarket Perform$230.00 ➝ $240.00High
11/11/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$253.00 ➝ $280.00Low
11/11/2020Piper SandlerBoost Price TargetOverweight$234.00 ➝ $236.00Low
11/6/2020TruistBoost Price Target$240.00 ➝ $260.00Low
11/6/2020Raymond JamesBoost Price TargetStrong-Buy$240.00 ➝ $250.00Medium
11/6/2020SVB LeerinkBoost Price TargetMarket Perform$207.00 ➝ $230.00High
8/3/2020Royal Bank of CanadaBoost Price TargetOutperform$266.00 ➝ $270.00Low
8/2/2020Royal Bank of CanadaReiterated RatingBuyLow
7/31/2020SVB LeerinkLower Price TargetMarket Perform$220.00 ➝ $207.00High
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$220.00Medium
6/5/2020BMO Capital MarketsBoost Price TargetOutperform$215.00 ➝ $242.00High
6/5/2020UBS GroupLower Price TargetBuy$252.00 ➝ $246.00High
6/5/2020The Goldman Sachs GroupBoost Price TargetBuy$244.00 ➝ $264.00High
5/4/2020BarclaysLower Price TargetOverweight$232.00 ➝ $229.00Medium
5/4/2020Raymond JamesBoost Price TargetStrong-Buy$210.00 ➝ $240.00Low
5/4/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$288.00 ➝ $279.00Low
5/4/2020Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$223.00Medium
5/1/2020Royal Bank of CanadaBoost Price TargetOutperform$249.00 ➝ $266.00High
4/13/2020Morgan StanleyBoost Price TargetOverweight$251.00 ➝ $258.00Low
4/13/2020SunTrust BanksLower Price TargetBuy$280.00 ➝ $240.00Medium
4/12/2020Royal Bank of CanadaReiterated RatingBuy$249.00Medium
3/27/2020Morgan StanleyBoost Price TargetOverweight$248.00 ➝ $251.00Low
3/24/2020Raymond JamesUpgradeOutperform ➝ Strong-BuyHigh
3/23/2020Raymond JamesLower Price TargetOutperform ➝ Outperform$240.00 ➝ $210.00High
2/25/2020Piper SandlerBoost Price TargetOverweight$236.00 ➝ $240.00High
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$258.00 ➝ $288.00Low
2/10/2020BMO Capital MarketsReiterated RatingOutperform$252.00Low
2/7/2020Evercore ISIInitiated CoverageHold$230.00Low
2/7/2020SunTrust BanksReiterated RatingBuy$280.00Low
2/7/2020Morgan StanleyBoost Price TargetOverweight$247.00 ➝ $248.00Medium
2/7/2020Raymond JamesBoost Price TargetOutperform$225.00 ➝ $240.00Medium
2/6/2020Cantor FitzgeraldReiterated RatingOverweight$245.00 ➝ $255.00Low
1/28/2020UBS GroupBoost Price TargetBuy$222.00 ➝ $244.00Low
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$245.00Medium
1/23/2020CitigroupBoost Price TargetBuy$221.00 ➝ $263.00Low
1/3/2020Raymond JamesUpgradeMarket Perform ➝ OutperformLow
1/2/2020StephensBoost Price TargetOverweight$242.00 ➝ $270.00Low
12/23/2019CowenReiterated RatingBuy$250.00N/A
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$225.00 ➝ $282.00High
12/19/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$210.00 ➝ $229.00Low
12/11/2019Wells Fargo & CompanyDowngradeMarket Perform ➝ Underperform$181.00Medium
11/25/2019CowenReiterated RatingBuy$240.00Low
11/6/2019MizuhoBoost Price TargetBuy$180.00 ➝ $205.00Medium
11/5/2019CitigroupReiterated RatingBuy$203.00 ➝ $221.00Low
11/1/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy$207.00 ➝ $210.00Medium
10/17/2019MizuhoInitiated CoverageBuy$180.00Medium
9/30/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$188.00Low
9/26/2019Morgan StanleyBoost Price TargetOverweight$207.00 ➝ $208.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$207.00High
9/10/2019OppenheimerSet Price TargetBuy$254.00High
8/23/2019StephensSet Price TargetBuy$225.00High
8/21/2019CitigroupReiterated RatingBuyMedium
8/6/2019Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$205.00Low
8/2/2019Raymond JamesBoost Price TargetOutperform$185.00 ➝ $190.00Low
7/12/2019Morgan StanleyLower Price TargetOverweight$241.00 ➝ $207.00Low
6/3/2019CitigroupLower Price TargetBuy$228.00 ➝ $203.00Medium
5/3/2019The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
4/23/2019UBS GroupInitiated CoverageBuy ➝ Buy$185.00Medium
4/21/2019Cantor FitzgeraldReiterated RatingBuy$245.00Low
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$220.00 ➝ $207.00Low
2/5/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$304.00 ➝ $299.00High
2/2/2019The Goldman Sachs GroupReiterated RatingBuyMedium
1/14/2019StephensInitiated CoverageOverweight$251.00Medium
1/7/2019Credit Suisse GroupReiterated RatingBuy$250.00Medium
1/6/2019BarclaysReiterated RatingBuy$220.00Low
1/3/2019Wells Fargo & CompanyLower Price TargetMarket Perform$221.00 ➝ $200.00Medium
1/3/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$187.17Low
1/2/2019Edward JonesInitiated CoverageBuyMedium
12/24/2018Edward JonesInitiated CoverageBuy ➝ Buy$181.30Low
12/13/2018Morgan StanleyInitiated CoverageOverweight$304.00Medium
11/19/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$250.00 ➝ $260.00Low
11/2/2018BarclaysBoost Price TargetOverweight ➝ Overweight$228.00 ➝ $235.00N/A
11/2/2018CitigroupBoost Price TargetBuy ➝ Buy$243.00 ➝ $249.00N/A
11/2/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Hold$220.00 ➝ $230.00Low
9/27/2018SunTrust BanksBoost Price TargetBuyLow
9/26/2018Cantor FitzgeraldInitiated CoverageOverweight$245.00Medium
9/21/2018SVB LeerinkBoost Price TargetOutperform$235.00 ➝ $250.00Low
9/18/2018Credit Suisse GroupBoost Price TargetOutperform$223.00 ➝ $237.00Medium
9/17/2018CowenInitiated CoverageOutperform$240.00High
8/3/2018SunTrust BanksBoost Price TargetBuy$244.00Low
8/3/2018Jefferies Financial GroupReiterated RatingBuy$224.00Low
6/6/2018The Goldman Sachs GroupUpgradeNeutral ➝ Buy$193.00 ➝ $212.00Medium
5/4/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$215.00 ➝ $218.00N/A
3/13/2018Sanford C. BernsteinInitiated CoverageMkt Perform ➝ Market Perform$194.00Medium
3/12/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$232.00 ➝ $215.00High
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$235.00High
2/2/2018OppenheimerBoost Price TargetOutperform$237.00Medium
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$255.00Low
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$247.00Medium
11/3/2017CitigroupBoost Price TargetBuy$198.00 ➝ $231.00N/A
11/3/2017Morgan StanleyBoost Price TargetOverweight$195.00 ➝ $223.00N/A
11/3/2017Jefferies Financial GroupBoost Price TargetBuy$221.00 ➝ $231.00N/A
11/3/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$185.00 ➝ $220.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$219.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageMarket Perform$210.00N/A
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$201.00 ➝ $221.00N/A
9/17/2017Piper Jaffray CompaniesReiterated RatingBuy$191.00Low
8/17/2017Morgan StanleyBoost Price TargetOverweight$188.00 ➝ $195.00Low
8/9/2017Royal Bank of CanadaReiterated RatingBuy$185.00High
8/7/2017CitigroupBoost Price TargetBuy$185.00 ➝ $198.00Low
8/7/2017Morgan StanleyBoost Price TargetOverweight$184.00 ➝ $188.00Low
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$180.00 ➝ $190.00Low
8/4/2017Credit Suisse GroupReiterated RatingBuy$196.00High
8/4/2017Jefferies Financial GroupReiterated RatingBuy$199.00 ➝ $190.00Low
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$175.00Medium
7/24/2017Royal Bank of CanadaReiterated RatingBuy$182.00Low
7/14/2017Credit Suisse GroupReiterated RatingOutperform$190.00 ➝ $193.00Low
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$175.00 ➝ $180.00Low
6/23/2017Bank of AmericaBoost Price TargetBuy$193.00 ➝ $198.00Medium
6/22/2017UBS GroupReiterated RatingBuy$186.00 ➝ $193.00N/A
6/22/2017Royal Bank of CanadaBoost Price TargetOutperform$177.00 ➝ $182.00Low
6/19/2017Wells Fargo & CompanyReiterated RatingMarket Perform$163.00 ➝ $174.00Low
6/15/2017CIBCBoost Price TargetOutperform$174.00 ➝ $185.00Medium
6/15/2017OppenheimerBoost Price TargetOutperform$174.00 ➝ $185.00Low
6/13/2017Royal Bank of CanadaReiterated RatingBuy$177.00Low
6/12/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$185.00Low
6/8/2017Jefferies Financial GroupReiterated RatingBuy$183.00Medium
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$184.00High
6/5/2017UBS GroupReiterated RatingBuy$181.00 ➝ $186.00N/A
6/1/2017CowenReiterated RatingOutperform$160.00 ➝ $185.00Low
5/15/2017Stifel NicolausBoost Price TargetBuy$170.00 ➝ $175.00N/A
5/15/2017Royal Bank of CanadaBoost Price TargetOutperform$172.00 ➝ $177.00N/A
5/15/2017Jefferies Financial GroupBoost Price TargetBuy$178.00 ➝ $183.00N/A
5/10/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$172.00 ➝ $175.00Low
5/8/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$172.00 ➝ $177.00Medium
5/5/2017Jefferies Financial GroupReiterated RatingBuy$178.00 ➝ $183.00Medium
5/5/2017Stifel NicolausBoost Price TargetBuy$170.00 ➝ $175.00Low
4/23/2017Jefferies Financial GroupReiterated RatingBuy$172.00 ➝ $178.00Low
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$172.00Low
3/13/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$175.00Low
2/16/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$172.00N/A
2/10/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$172.00N/A
2/6/2017OppenheimerReiterated RatingOutperform$158.00 ➝ $164.00N/A
2/3/2017Royal Bank of CanadaReiterated RatingHold$151.00N/A
2/3/2017Jefferies Financial GroupReiterated RatingBuyN/A
1/23/2017CitigroupBoost Price TargetBuy$139.00 ➝ $163.00N/A
1/4/2017Piper Jaffray CompaniesInitiated CoverageOverweight$170.00N/A
11/7/2016Jefferies Financial GroupReiterated RatingBuy$153.00 ➝ $149.00N/A
10/16/2016Jefferies Financial GroupReiterated RatingBuy$153.00N/A
9/26/2016SVB LeerinkReiterated RatingBuy$155.00N/A
9/22/2016Evercore ISIInitiated CoverageHold$134.00N/A
9/8/2016The Goldman Sachs GroupReiterated RatingBuy$160.00N/A
8/31/2016UBS GroupReiterated RatingBuyN/A
8/31/2016William BlairReiterated RatingBuyN/A
8/23/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/3/2016CitigroupLower Price TargetBuy$174.00 ➝ $146.00N/A
8/1/2016Jefferies Financial GroupLower Price TargetBuy$160.00 ➝ $153.00N/A
8/1/2016SVB LeerinkLower Price TargetOutperform$160.00 ➝ $155.00N/A
(Data available from 7/24/2016 forward)
Cigna logo
Cigna Corp. engages in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions. The U.S. Medical segment includes Cigna's U.S. Commercial and U.S. Government businesses that provide comprehensive medical and coordinated solutions to clients and customers. The International Markets segment includes supplemental health, life and accident insurance products and health care coverage in international markets, as well as health care benefits to globally mobile employees of multinational organizations. The Group Disability and Other segment represents group disability and life, corporate-owned life insurance, and run-off business consisting of reinsurance; settlement authority; and individual life insurance and annuity and retirement benefits business. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Read More

Today's Range

Now: $232.88
Low: $232.10
High: $234.12

50 Day Range

MA: $243.44
Low: $227.63
High: $264.72

52 Week Range

Now: $232.88
Low: $158.84
High: $272.81

Volume

1,103,237 shs

Average Volume

1,783,240 shs

Market Capitalization

$79.91 billion

P/E Ratio

10.01

Dividend Yield

1.72%

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Cigna?

The following Wall Street research analysts have issued reports on Cigna in the last year: BMO Capital Markets, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, Piper Sandler, Raymond James, Royal Bank of Canada, SVB Leerink LLC, Truist, Truist Financial Co., Truist Securities, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for CI.

What is the current price target for Cigna?

14 Wall Street analysts have set twelve-month price targets for Cigna in the last year. Their average twelve-month price target is $283.44, suggesting a possible upside of 21.4%. Morgan Stanley has the highest price target set, predicting CI will reach $321.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $235.22 for Cigna in the next year.
View the latest price targets for CI.

What is the current consensus analyst rating for Cigna?

Cigna currently has 2 hold ratings, 9 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CI will outperform the market and that investors should add to their positions of Cigna.
View the latest ratings for CI.

What other companies compete with Cigna?

Other companies that are similar to Cigna include UnitedHealth Group, Anthem, Humana, Centene, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Cigna's investor relations team?

Cigna's physical mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider's listed phone number is (860) 226-6000 and its investor relations email address is [email protected] The official website for Cigna is www.cigna.com.